Clinical Trial Update: Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SBG to placebo in head and neck cancer patients undergoing radiation therapy, assessing efficacy and safety; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• SBG

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Head and Neck Cancer, Oral Mucositis | Phase 3 | Status: COMPLETED